Metabolic Phenotyping Predicts Gemcitabine and Cisplatin Chemosensitivity in Patients With Cholangiocarcinoma. (2022)

First Author: Suksawat M

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.3389/fpubh.2022.766023

PubMed Identifier: 35223723

Publication URI: http://europepmc.org/abstract/MED/35223723

Type: Journal Article/Review

Volume: 10

Parent Publication: Frontiers in public health

ISSN: 2296-2565